Business & Finance
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Key Points
Novo’s share price is languishing about 70 percent below its peak from mid-2024, when it was Europe’s most valuable public company.
Novo’s share price is languishing about 70 percent below its peak from mid-2024, when it was Europe’s most valuable public company.
[Image text:] NDC0169-4425-31
List442531
wegovy
R
25 mg
(semaglutide) Tablets
25 mg
Rx only
DISPENSE WITH
MEDICATION GUIDE
30 tablets
novo nordisk
25